Skip to main content

Advertisement

ADVERTISEMENT

News

Debrichem - DEBx Medical 

https://clinicaltrials.gov/study/NCT06652360

DEBx Medical has initiated a 40-patient pilot RCT to examine the safety/efficacy of chemical debridement and curettage in treatment of venous and mixed etiology leg ulcers with primary outcome of percentage wound reduction at 12 weeks. Not yet recruiting; estimated completion is April 2025. clinicaltrials.gov

Advertisement

Advertisement

Advertisement